MRC Institute of Genetics & Molecular Medicine
MRC Institute of Genetics & Molecular Medicine

ECDU and Edinburgh University have sealed a deal with the American drugs Giant Eli Lilly

Edinburgh Cancer Discovery Unit make a deal to develop new drugs to fight cancer: October 2013

The Edinburgh Cancer Discovery Unit (ECDU) and Edinburgh University have sealed a deal this week with the American drugs Giant Eli Lilly to develop new drugs in the fight against cancer. The ECDU will be providing expertise and cutting edge biological techniques to help Lilly identify which of its chemical compounds may be effective as anti-cancer therapies.

Neil Carragher, Principal Investigator of the ECDU and Edinburgh Cancer Research Centre said “The collaboration provides an excellent opportunity to partner the latest innovations in cancer research from the ECDU with compounds from Lilly’s oncology pipeline.”

For the full story please see the Scotsman website:

Related Links

Scots cancer researchers in deal with US drugs giant: The Scotsman 21 October 2013